A top 10 pharma company faced challenges in standardizing safety surveillance across Pharma, Vaccine, and Consumer Health units, including consolidating signal teams, facilitating a divestment, integrating multiple data sources, migrating data from legacy systems, replacing existing methods, and simplifying the IT landscape.
The timely deployment of Qinecsa’s CVW significantly benefited the client by increasing operating efficiency, combining Pharma and Vaccine units, enhancing process visibility and improving audit readiness, thus standardizing safety surveillance and streamlining operations for future success.
